A small-molecule antagonist of virion assembly

Expert Opinion on Investigational Drugs

Volumn 10, Issue 9, 2001, Pages 1767-1770

  Neamati, N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Analogues; Antagonist; Anti HIV; Assembly; Betulinic acid; Novel; Virion

Indexed keywords

3 O (3,3 DIMETHYLSUCCINYL)BETULIC ACID; 4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BETULIC ACID; CURDLAN; PLATONIC ACID; RITONAVIR; UNCLASSIFIED DRUG; YK FH 312; ZIDOVUDINE;

ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; MELANOMA; MOUSE; NONHUMAN; VIRION; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; MOLECULAR WEIGHT; TRITERPENES; VIRION; VIRUS ASSEMBLY;

EID: 0034845991     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.10.9.1767     Document Type: Article

References (27)

1. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation
2. Betulinic acid derivatives: A new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action
3. Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41
4. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells
5. Betulinic acid derivatives: A new class of specific inhibitors of human immunodeficiency virus type 1 entry
6. Anti-HIV triterpene acids from Geum japonicum
7. Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase
8. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
9. Mitochondrion as a novel target of anticancer chemotherapy
10. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid
11. Synthesis of betulinic acid derivatives with activity against human melanoma
12. Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: Evidence for a potential role as a chemopreventive agent
13. Betulinic acid inhibits aminopeptidase N activity
14. Betulinic acid: A new chemotherapeutic agent in the treatment of neuroectodermal tumors
15. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
16. Betulinic acid induces apoptosis in human neuroblastoma cell lines
17. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
18. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
19. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing
20. DNA polymerase beta inhibitors from Tetracera boiviniana
21. Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα
22. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stage carcinogenesis
23. Induction of p53 without increase in p21 WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma
24. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
25. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice
26. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564
27. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents